NOV 10, 2017 7:25 AM PST

New Generation of Antibiotics Kills Bacteria with Impeccable Precision

WRITTEN BY: Kara Marker

The only way to overcome multidrug-resistant bacteria is to design a drug that bacteria have never encountered. In a new study funded by the São Paulo Research Foundation, scientists are doing just that, with a new drug specifically designed to target bacillus bacteria.

Pseudomonas aeruginosa, Enterococcus faecalis and Staphylococcus aureus on Tryptic Soy Agar. Credit: Wikimedia User HansN

“The problem of drug-resistant bacteria is serious and hasn't been given proper attention by either governments or the pharmaceutical industry,” explained project coordinator Andréa Dessen. “We can no longer ignore it.”

Dessen and other scientists from France’s Institute of Structural Biology and Brazil’s National Bioscience Laboratory focused their efforts on new treatments for drug-resistant bacillus bacteria. Famous bacillus include Escherichia coli, Pseudomonas aeruginosa and Helicobacter pylori. Current antibiotics primarily target components unique to the bacterial cell wall, but the new approach prevents bacteria from ever building their cell wall, making each bacterial cell “not only more vulnerable but also incapable of reproducing itself.”

"The cell wall is a mesh like a fishing net, made up largely of peptidoglycan, a polymerized blend of sugars and amino acids associated with peptides," Dessen explained. "It protects the bacterium against differences in osmotic pressure and ensures the cell is the right shape.”

Bacilli bacteria contain a multiprotein complex called the elongasome that require binding of specific proteins after cell division to obtain the right shape. The elongasome was the subject of Dessen’s new study, where researchers isolated two proteins, PBP2 and MreC, to understand the complex’s three-dimensional structure using X-ray diffraction crystallography. This technology enabled researchers to observe how the two proteins interact, and, subsequently, how to prevent this interaction.

Brazilian and French scientists show that inhibiting the interaction of two key proteins for cell wall elongation can be an effective strategy to kill bacteria of the bacillus type. Image: Nature Communications

Next, researchers altered the amino acids in MreC that interact with PBP2, which prevented the two proteins from interacting and the elongasome from forming. Then, they genetically modified H. pylori bacteria to express the same mutant MreC protein, and they were subsequently unable to grow because their cell wall did not form correctly.

“The experiment proved the importance of the PBP2-MreC complex to elongation of the wall and survival of bacilli,” Dessen explained. “This knowledge can be used to seek molecules capable of interrupting the interaction between these proteins and thereby kill the bacillus."

The study’s approach, however, would be effective only against bacterial species with elongated cell walls. Most bacteria do have cell walls, but some do not - for example, an extremely deadly pathogen with acquired resistance to most available drugs, Acinetobacter baumannii. Further research will have to be completely to expand this approach to other types of bacteria.

The present study was published in the journal Nature Communications.

Source: São Paulo Research Foundation

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
SEP 25, 2019
SEP 25, 2019
Your Immune Response Varies from AM to PM
“My biological clock is ticking.” We’ve heard people say this phrase - maybe even said it ourselves - but what do we mean exactly? Often...
OCT 19, 2019
OCT 19, 2019
Autism May be Linked to an Immune Disorder
Until now, diagnosis for autism spectrum disorder have relied on behavioral assessments looking for symptoms including poor social and communication skills...
OCT 31, 2019
OCT 31, 2019
Unpacking lactate's role in the Warburg effect
In a recent issue of Nature, the findings of one study made a particularly big splash: how and why cancer cells use energy differently than healthy cells. ...
NOV 08, 2019
NOV 08, 2019
Measles Can Wipe Out the Memory of the Immune System
Researchers have learned how the measles vaccine can provide an additional layer of protection against more than just the measles....
NOV 28, 2019
Drug Discovery & Development
NOV 28, 2019
Immunotherapy Drug Shows Promise for Treating Advanced Prostate Cancer
By the end of the year, an estimated 175,000 men in the United States will have been diagnosed with prostate cancer. Now, researchers from the UK have foun...
JAN 22, 2020
JAN 22, 2020
How the VISTA molecule affects immune responses
A new study describes how a molecule named VISTA has been impeding immune responses in cancer therapies. By turning this molecule “off,” resear...
Loading Comments...